|
Eris Lifesciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
15877.24 Cr.
|
P/BV
|
3.92
|
Book Value (Rs.)
|
291.66
|
|
52 Week High/Low (Rs.)
|
1740/1138
|
FV/ML
|
1/1
|
P/E(X)
|
25.63
|
|
Bookclosure
|
29/05/2026
|
EPS (Rs.)
|
44.65
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 638.54 | 488.87 | 431.24 | 404.64 | 442.20 |
| | | | | | |
| Net CashFlow From Operating Activities | 537.99 | 1065.01 | 486.01 | 291.74 | 378.26 |
| Net Cash Used In Investing Activities | -369.46 | -79.97 | -1854.52 | -982.10 | -319.61 |
| Net Cash Used From Financing Activities | -313.53 | -881.32 | 1379.78 | 688.03 | -44.70 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | 1.77 | 0.00 | 7.49 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -145.00 | 105.49 | 11.26 | 5.15 | 13.96 |
| Cash And Cash Equivalents Begin of Year | 199.74 | 94.25 | 82.98 | 50.87 | 36.92 |
| Cash And Cash Equivalents End Of Year | 54.74 | 199.74 | 94.25 | 56.02 | 50.87 |
